USPTO Patents Application 10561839

PTO/SB/08a (08-03)
Approved for use through 07/31/2006. OMB 0651-0031
U.S.Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are reqiiired to respond to a collection of informatioii unless it contains a valid OMB control numba:.

Substitute for form 1449A/PTO

INFORMATION DISCLOSURE
STATEMENT BY APPLICANT

{use as many sheets as necessary)

Complete if Known

Application Number

Filing Date

First Named Inventor

Art Unit

Examiner Name

10/561,839

June 05, 2006

DEUTSCH Mordechai et al

1774

EDWARDS Lydia E.

Sheet

of

Attorney Docket Number

30024

U.S. PATENT DOCUMENTS

Examiner
Initials*

Cite
No. ^

Document Number

Number-Kind Code^^'^'^^""^

Publication Date
DD-MMM-YYYY

Name of Patentee or
Applicant of Cited Dociunent

Pages, Coliunns, lines. Where
Relevant Passages or Relevant
Figures Appear

4,072,578

07-Feb-1978

Cady et al.

FOREIGN PATENT DOCUMENTS

Examiner
Initials*

Cite
No. ^

Foreign Patent Documents

Country Code^" Number"^" Kind Code^ {if known)

Publication Date
DD-MMM-YYYY

Name of Patentee or
Applicant of Cited Document

Pages, Columns, Lines,
Where Relevant Passages
or Relevant Figures Appear

WO 02/08748

31-Jan-2002

Maher et al.

WO 99/66329

23-Dec-1999

Owen et al.

Examiner
Signature

Date

Considered

EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered.
Include copy of copy of this form with next communication to appUcant.
^ Applicant's unique citation designation number (optional).

^ See Kinds Codes of UvSPTO Patent Documents at www.uspto.gov or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3).
3

Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3).

4

For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial nmnber of the patent document.
Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST. 16 if possible.
^ Applicant is to place a check mark here if English language translation is attached.

This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to
process) an appUcation. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. this collection is estimated to take 2 hours to complete, including gathering, preparing, and
submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this
form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of commerce, P.O. Box
1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450,
Alexandria, VA 22313-1450

PTO/SB/08a (08-03)
Approved for use through 07/31/2006. OMB 0651-0031
U.S.Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE

Substitute for form 1449A/PTO

INFORMATION DISCLOSURE
STATEMENT BY APPLICANT

(use as many sheets as necessary)

Complete if Known

Application Number

10/561,839

Filing Date

June 05, 2006

First Named Inventor

DEUTSCH Mordechai et al

Group Art Unit

1774

Examiner Name

EDWARDS Lydia E.

Sheet 2

Of 2

Attorney Docket Number

30024

OTHER PRIOR ART - NON PATENT LITERATURE DOCUMENTS

Examiner
Initials

Cite
No.^

Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the
item (book, magazine, journal, serial symposium, catalog, etc.) date, page(s), volume-issue number(s),
publisher, city and/or country where published.

European Search Report and the European Search Opinion Dated 01 August 201 1
From the European Patent Office Re. AppUcation No. 10183774.8.

Gonzalez et al. "Cell-Based Assays and Instrumentation for Screening Ion-Channels
Targets", Drug Discovery Today, DDT, XP001026838, 4(9): 431-439, 01
September 1999.

Examiner

Date

Signature

Considered

EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered.
Include copy of copy of this form with next communication to applicant.
^ Applicant's unique citation designation number (optional).

^ See Kinds Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04. 3 Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3).

^ Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3).
4

For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
^ Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST. 16 if possible.

Applicant is to place a check mark here if English language translation is attached.
This collection of information is required by 37 CFR 1 .97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to
process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. this collection is estimated to take 2 hoiirs to complete, including gathering, preparing, and
submitting the completed application form to the USPTO. Time will wary depending upon the individual case. Any comments on the amount of time you require to complete this
form and/or suggestions for reducing this burden, should be sent to the Cliief Information Ofticer, U.S. Patent and Trademark Oftice, U.S. Department of commerce, P.O. Box 1450,
Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA
22313-1450

If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.